ARTICLE | Clinical News

Puricase pegloticase: Additional Phase III data

May 12, 2008 7:00 AM UTC

Savient reported data from 81 patients enrolled in the open-label extension of 2 Phase III trials of Puricase to treat gout. Of the patients who responded in the Phase III trials, 100% and 70% of thos...